TSXV/GSD (TSXV/GSD)

TSX Venture Exchange: TSXV/GSD · CAD

CA$6.75

-0.75 (-10.0%)· Recorded snapshot

Market cap	18.8M
Revenue (ttm)	3M
Net income (ttm)	-6.1M
EPS (ttm)	-CA$2.26
Shares out	2.8M
Volume	1,348
Beta	1.14

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3M
Net income (ttm): -6.1M
EPS (ttm): -CA$2.26
Market cap: 18.8M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 11.1P50 16.7P75 23.4

Trailing P/En/a

P25 9.7P50 23.2P75 38.2

ROE-77.3

P25 -102.4P50 -28.4P75 6.8

ROIC-94.1

P25 -55.9P50 -11.8P75 5.8

Benchmarks · 1M

All TSXV/GSD indicators

Market & fundamental data

Available fields

180

Groups with data

Currency

CAD

Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-26
Employees	11
Employees change	3
Employees growth	37.5%
Enterprise value	CAD 18.2M
Exchange	TSX Venture Exchange
Financial currency	CAD
Financial report date	2026-04-30
First seen	2026-05-10
Fiscal year end	July
Founded	2017
Industry	Biotechnology
Is primary listing	Yes
ISIN number	CA2518348834
Last earnings date	2025-11-28
Last refreshed	2026-10-28
Last stock split date	2026-01-22
Last stock split type	Reverse
Market cap	CAD 18.8M
Next earnings date	2026-11-26
Price	CAD 6.75
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	tsxv/GSD
Website	https://groupedevonian.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-33.54%
EV/Sales	6.77x
FCF / EV yield	-58.06%
FCF yield	-56.45%
P/B ratio	2.99x
P/S ratio	6.96x
Price / tangible book value	10.04x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-206.69%
EBITDA margin	-197.67%
Gross margin	67.89%
Operating margin	-206.69%
Pretax margin	-204.51%
Profit margin	-204.08%
Profit per employee	CAD -611,280
Revenue per employee	CAD 299,526
ROA	-24.5%
ROA (5Y)	-7.23%
ROCE	-87.97%
ROE	-77.33%
ROE (5Y)	-32.8%
ROIC	-94.06%
SBC / revenue	48.55%
Tax / revenue	-0.42%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Gross profit growth	-82.68%
Gross profit growth (Q)	-92.71%
Gross profit growth 3Y	43.34%
Revenue growth	-90.77%
Revenue growth (Q)	-97.6%
Revenue growth (QoQ)	-63.79%
Revenue growth 3Y	16.77%
Revenue growth 5Y	15.39%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -6,500
Depreciation and amortization	CAD 269,974
EBIT	CAD -6.2M
EBITDA	CAD -5.9M
EPS	CAD -2.26
FCF per share	CAD -4.23
Financing cash flow	CAD 2.7M
Free cash flow	CAD -11.8M
Free cash flow minus SBC	CAD -13.2M
Gross profit	CAD 2M
Income taxes	CAD -12,684
Investing cash flow	CAD -6,500
Net borrowing	CAD 111,138
Net cash flow	CAD -9M
Net income	CAD -6.1M
Operating cash flow minus SBC	CAD -13.2M
Operating income	CAD -6.2M
Revenue	CAD 3M
Stock-based compensation	CAD 1.5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.12
Book value per share	CAD 2.51
Debt / equity	0.02
Interest coverage	-155.7
Long-term assets	CAD 7M
Long-term liabilities	CAD 59,917
Net cash (debt)	CAD 579,389
Net cash / market cap	2.78%
Net cash growth	-93.98%
Net debt / equity	-0.08
Piotroski F-Score	1
Property, plant and equipment	CAD 2.1M
Shareholders' equity	CAD 7M
Tangible book value	CAD 2.1M
Tangible book value per share	CAD 0.75
Total assets	CAD 8.6M
Total cash	CAD 719,932
Total debt	CAD 140,543
Total liabilities	CAD 1.7M
WACC	10.59%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.19
Current assets	CAD 1.6M
Current liabilities	CAD 1.6M
Current ratio	1
Inventory turnover	35.76
Net working capital	CAD -644,483
Quick ratio	0.78
Working capital	CAD -5,177
Working capital turnover	3.45

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-9.29%
Shareholder yield	-9.29%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 10.11
1D price change	-10%
1M price change	-24.58%
1M total return	-24.58%
1W price change	-4.93%
1W total return	-4.93%
1Y price change	-37.5%
1Y return CAGR	-37.52%
1Y total return	-37.5%
20-day SMA	CAD 7.97
200-day SMA	CAD 10.28
3M price change	-20.59%
3M total return	-20.59%
3Y price change	-48.86%
3Y return CAGR	-20.03%
3Y total return	-48.86%
50-day SMA	CAD 8.65
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 15.00
52-week high date	2025-11-24
52-week low	CAD 5.10
52-week low date	2026-07-07
5Y price change	-73.21%
5Y return CAGR	-23.16%
5Y total return	-73.21%
6M price change	-43.28%
6M total return	-43.28%
All-time high	CAD 57.00
All-time high date	2017-05-19
All-time low	CAD 4.50
All-time low date	2024-10-29
Average true range (ATR)	CAD 0.65
Average volume	4.1K
Beta (1Y)	0.62
Beta (2Y)	0.91
Beta (5Y)	1.14
Change from 52-week high	-55%
Change from 52-week low	32.35%
Change from all-time high	-88.16%
Change from all-time low	50%
Change from open	-10%
Day's gap	0%
Dollar volume	CAD 9,099
High price	CAD 7.50
Low price	CAD 6.75
Monthly RSI	41.22
Open price	CAD 7.50
Position in 52-week range	0%
Previous close	CAD 7.50
Price vs 150-day SMA	-33.23%
Price vs 20-day SMA	-15.3%
Price vs 200-day SMA	-34.36%
Price vs 50-day SMA	-21.94%
Relative volume	0.33
RSI	39.88
Sharpe ratio	0.96
Sharpe ratio (3Y)	1.01
Sortino ratio	1.69
Sortino ratio (3Y)	1.76
Volume	1.3K
Weekly RSI	40.56
YTD price change	-40.79%
YTD total return	-40.79%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.9M
Shares change (QoQ)	0.1%
Shares change (YoY)	9.29%
Shares held by insiders	6.48%
Shares held by institutions	0.29%
Shares outstanding	2.8M

Deeper analysis on TSXV/GSD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSXV/GSD report

Is a complete TSXV/GSD research report available?

No complete published report is available for tsxv/GSD (TSXV/GSD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSXV/GSD (TSXV/GSD)

Price

Financial snapshot

Fair-value bridge

Latest news · TSXV/GSD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSXV/GSD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSXV/GSD

Frequently asked questions